Archive ready

2024年3月期 決算短信〔日本基準〕(連結)

https://www.jintan.co.jp/corp/ir/uploads/20240509.pdf
July 1, 2026 at 05:05 PM JSTThe archive page, viewer, and downloads use this saved version.
July 1, 2026 at 05:05 PM JST·www.jintan.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

2024年3月期 決算短信〔日本基準〕(連結)

StartedJuly 1, 2026 at 05:05 PM JST
File size0.29 MB
SHA-25663c2e7e98489092d044ba3b9894b1ce024ccf44005098de39bb75fd084eaf20e
About this pageAI generated

This document presents the financial results for the fiscal year ending March 2024 of Morishita Jintan Co., Ltd. The consolidated sales for the fiscal year were 12,406 million yen, marking a 9.2% increase compared to the previous year. Operating profit reached 716 million yen, while ordinary profit was 815 million yen, and net profit attributable to shareholders was 697 million yen, all exceeding the previous year's figures. The equity ratio stands at 70.7%, indicating a stable financial foundation. Additionally, a dividend of 50 yen per share has been declared, and forecasts for the fiscal year ending March 2025 are also provided. Overall, the document highlights a recovery in sales within the healthcare business, reflecting improvements in economic conditions.